Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CV 4151

Known as: CV-4151 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Effects of thromboxane A2 (TXA2) synthase inhibitors (CV-4151 and ozagrel) on cerebral thrombosis and cerebral damage were… Expand
Is this relevant?
1994
1994
We established an experimental model of late asthmatic response (LAR) using conscious guinea pigs actively sensitized by antigen… Expand
Is this relevant?
1991
1991
Thromboxane A2 (TXA2), leukotrienes (LTs) and free radicals are considered to be possible mediators in the induction of… Expand
Is this relevant?
Highly Cited
1989
Highly Cited
1989
This study was undertaken to compare age-related changes in endothelium-dependent vascular responses in both hypertensive and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1989
1989
To assess the role of neutrophils and arachidonate metabolites in evolving myocardial infarction, the effect of inhibitors of… Expand
Is this relevant?
1988
1988
The thromboxane A2/prostaglandin endoperoxide (TXA2/PGH2) receptor antagonist activity of CV-4151, a potent TXA2 synthetase… Expand
Is this relevant?
1986
1986
(E)-7-Phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151) inhibited horse platelet microsomal thromboxane (TX) A2 synthetase with an… Expand
Is this relevant?
1986
1986
The protective effect of a novel thromboxane (TX) synthetase inhibitor, (E)-7-phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151), on… Expand
Is this relevant?
1985
1985
When CV-4151, a specific thromboxane (TX) A2 synthetase inhibitor, was given orally to 4 week old (4w) spontaneously hypertensive… Expand
Is this relevant?
1985
1985
A novel series of omega-pyridylalkenoic acids has been prepared by applying the Wittig reaction. Modifications were made in the… Expand
Is this relevant?